Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.3.2) was added to the page history, and the previous revision (v3.3.1) was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a new Revision: v3.3.1 replacing v3.2.0, indicating a system/UI update. No study data, trial details, or core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding/status notice banner was removed from the page in the latest version, affecting only the UI banner and not the trial records or study details.SummaryDifference0.4%

- Check43 days agoChange DetectedNew screenshot shows minor UI/layout adjustments to the Record History page; the version list and primary content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference10%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.